Prognostic & predictive markers utilized in breast
cancer
ER/PR status
HER2 neu status
19-9-2017
Prognostic (recurrence risk)
Predictive (treatment benefit)
Axillary node status
Histologic type/grade/proliferation
index
Tumor size
Patient age
Performance status
Lymphatic/Vascular invasion
ER/PR status
HER2 neu status
Oncotype DX test
70 gene signature (mammaprint)




